Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SAU:2070's Cyclically Adjusted PB Ratio is ranked better than 54.8% of 646
companies
in the Drug Manufacturers industry
Industry Median: 1.725
vs SAU:2070: 1.52
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Saudi Pharmaceutical Industries & Medical Appliances's adjusted book value per share data for the three months ended in Jun. 2026 was ï·¼14.146. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ï·¼20.48 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Cyclically Adjusted PB Ratio Explanation
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PB Ratio Related Terms
Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PB Ratio Chart
Saudi Pharmaceutical Industries & Medical Appliances Annual Data
SAU:2070 vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Pharmaceutical Industries & Medical Appliances's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry
Saudi Pharmaceutical Industries & Medical Appliances Cyclically Adjusted PB Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PB Ratio of 1.52 mean?
Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) has a Cyclically Adjusted PB Ratio of 1.52 as of Aug. 27, 2026. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors. This is near median its historical median of 1.42. Over the past decade, Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted PB Ratio has ranged from 0.85 to 2.41. According to the industry distribution chart, Saudi Pharmaceutical Industries & Medical Appliances ranks #292 out of 646 companies in the Drug Manufacturers industry, placing it in the top 45.2%.
Is Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted PB Ratio too high?
Saudi Pharmaceutical Industries & Medical Appliances' current Cyclically Adjusted PB Ratio of 1.52 is near median its 10-year median of 1.42. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 2.41. The Drug Manufacturers industry median Cyclically Adjusted PB Ratio is 1.73. Saudi Pharmaceutical Industries & Medical Appliances' value of 1.52 is 11.9% below this industry median. Based on the distribution chart, Saudi Pharmaceutical Industries & Medical Appliances ranks #292 out of 646 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Saudi Pharmaceutical Industries & Medical Appliances has a GF Scoreâ„¢ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Pharmaceutical Industries & Medical Appliances' Cyclically Adjusted PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Saudi Pharmaceutical Industries & Medical Appliances ranks #292 out of 646 companies for Cyclically Adjusted PB Ratio. This puts Saudi Pharmaceutical Industries & Medical Appliances in the upper half of its industry. The industry median Cyclically Adjusted PB Ratio is 1.73. Saudi Pharmaceutical Industries & Medical Appliances' value of 1.52 is 11.9% below this benchmark. Historically, Saudi Pharmaceutical Industries & Medical Appliances' own Cyclically Adjusted PB Ratio has ranged from 0.85 to 2.41 over the past decade. While the company's 10-year median is 1.42 vs. the industry median of 1.73, Saudi Pharmaceutical Industries & Medical Appliances has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PB Ratio for a Drug Manufacturers company?
The median Cyclically Adjusted PB Ratio among Drug Manufacturers companies is 1.73, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saudi Pharmaceutical Industries & Medical Appliances's current Cyclically Adjusted PB Ratio of 1.52 is 11.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PB Ratio mean?
A high Cyclically Adjusted PB Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PB Ratio is the ratio of share price to a company's inflation-adjusted book value per share over a 10-year period. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors. For the Drug Manufacturers industry, the median Cyclically Adjusted PB Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saudi Pharmaceutical Industries & Medical Appliances's current Cyclically Adjusted PB Ratio is 1.52, which is near median its own 10-year median of 1.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Pharmaceutical Industries & Medical Appliances stock overvalued right now?
Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) is currently considered Fairly Valued. The stock's GF Value™ is ﷼31.65, compared to a current price of ﷼31.04 — trading 1.9% below its estimated fair value. The current Cyclically Adjusted PB Ratio is 1.52, which is near median its 10-year median of 1.42 and 11.9% below the Drug Manufacturers industry median of 1.73. Saudi Pharmaceutical Industries & Medical Appliances' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PB Ratio calculated?
Cyclically Adjusted PB Ratio is calculated from a company's financial statements. For Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070), the current Cyclically Adjusted PB Ratio is 1.52 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Overvalued in 2026?
Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances stock appears to be undervalued.
The current stock price of ï·¼31.04 is trading 1.9% below its estimated GF Value™ of ï·¼31.65.
GuruFocus considers Saudi Pharmaceutical Industries & Medical Appliances to be Fairly Valued.
Key valuation signals for SAU:2070:
Cyclically Adjusted PB Ratio: 1.52 (near median its 10-year median of 1.42)
GF Value™: ï·¼31.65 vs. price of ï·¼31.04 (1.9% below fair value)
Industry Position: 11.9% below the Drug Manufacturers median (#292 of 646)
No single metric tells the full story. See the SAU:2070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. The segments of the company are Pharmaceutical Manufacturing, Trading and Distribution services, and Healthcare Services, out of which the company derives maximum revenue from the Pharmaceutical Manufacturing segment. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria.
67GF Score
Get the complete analysis for SAU:2070
Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:2070 has been successfully added to your 
